हिन्दी
English
मराठी
বাংলা
தமிழ்
മലയാളം
ગુજરાતી
తెలుగు
ಕನ್ನಡ
ଓଡ଼ିଶା
Business
Tech
World
Health
NEWS
VIDEOS
PHOTOS
Web Stories
LIVE TV
GO
Latest
Assembly Election
India
Ahmedabad
Bengaluru
Chennai
Hyderabad
Kolkata
Mumbai
Pune
Cricket
Success Story
Entertainment
Hollywood
Music
Bollywood
Television
Regional
Movie Review
Lifestyle
Relationship
Travel
Food & Recipes
Fashion
Culture
Spirituality
Business
Economy
Markets
Companies
Real Estate
International Business
Personal Finance
Automobile
Technology
Gadgets
Gaming
Internet & Social Media
Apps
Mobiles
World
Asia
Africa
Americas
Australia-Oceania
Europe
Auto
Mobility
Viral
Diabytes
Fables of Facades
Archived Videos
Newsletter
Fables of Facades
Latest
Assembly Election
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Latest
Assembly Election
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Advertisement
X
News
Pharmaceuticals industries
Pharmaceuticals industries News
Glenmark Pharmaceuticals
29 Oct 2015
Glenmark Q2 net up 20% at Rs 198 crore
Glenmark Pharmaceuticals Thursday reported 19.81 percent increase in consolidated net profit to Rs 197.78 crore for the second quarter ended September 30, driven by good growth in India, US and Europe.
GlaxoSmithKline Pharmaceuticals
08 Jun 2015
Glaxo considering all options against CCI order
Slapped with a penalty of nearly Rs 61 crore by competition watchdog CCI, GlaxoSmithKline Pharmaceuticals Monday said it would review the order and consider all options, including filing an appeal.
Glenmark Pharmaceuticals
19 May 2015
Glenmark issues over 1 cr shares to Aranda, raises Rs 945 cr
Glenmark Pharmaceuticals has raised Rs 945 crore by issuing over 1 crore shares to Aranda Investments, an indirect subsidiary of Temasek Holdings.
SEBI
14 Oct 2014
SEBI fines Glaxo for delayed disclosure in Indian listed arm
Capital market watchdog SEBI Tuesday slapped a fine of Rs 25 lakh on Glaxo Group Ltd, a promoter entity of drug maker Glaxo Smithkline Pharmaceuticals, for failing to make timely disclosures about its aggregate shareholding to the company and the stock exchanges.
738908
1
0
Loading...
Trending news
DNA Video
DNA: Anmol Bishnoi Seeks Asylum in the U.S.
DNA Video
DNA: Adani Case - Corruption Allegations Rock Indian Markets
DNA Video
DNA: Were Muslims Stopped from Voting in UP By-Elections?
DNA Video
DNA: Who Did Maharashtra’s Muslims Vote For?
DNA Video
DNA: Russia-Ukraine Conflict Escalates Amid Missile Attacks
DNA Video
DNA: The Beer-Loving Buffalo Stuck in Bihar!
DNA Video
DNA: Akhilesh and the Burqa Controversy in UP Elections
DNA Video
DNA: Is the Opposition to ‘Bantenge To Katenge’ Part of a Larger Plan?
DNA Video
DNA: RSS Master Plan: From Maharashtra to UP
DNA Video
DNA: Bengal’s Waqf Property Controversy
Subscribe Now
×
Enroll for our free updates
Please enter full name.
Please enter valid email address.
https://zeenews.india.com/
Subscribe Now
Thank you
×
Cookies Settings
Reject
Accept Cookies
NEWS ON ONE CLICK